Epidermal growth factor receptor (EGFR) is one of the most targeted driver genes, and its activating mutation is especially prevalent in the Eastern Asian lung adenocarcinoma (LUAD) population [1]. The gene discussed is EGFR; the disease is lung adenocarcinoma.